XLO - Xilio Therapeutics, Inc.
8.57
0.220 2.567%
Share volume: 40,392
Last Updated: 04-17-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.19%
PREVIOUS CLOSE
CHG
CHG%
$8.35
0.22
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-08-2024 | 11-07-2024 | 03-11-2025 | 05-08-2025 | 11-13-2025 | 03-23-2026 | |
| Cash flow financing | 954.000 K | 20.043 M | -3.000 K | 8.202 M | 4.832 M | -285.000 K | 35.866 M | |
| Other financing cash flows | -21.000 K | -20.000 K | -3.000 K | 0.000 | 5.000 K | 0.000 | 1.000 K | |
| Cash flow | -9.548 M | 39.975 M | -13.684 M | -5.961 M | 33.788 M | 0.000 | 33.773 M | |
| Net income | -17.203 M | -13.925 M | -14.020 M | -13.093 M | -13.265 M | -907.000 K | -5.020 M | |
| Depreciation | 443.000 K | 445.000 K | 381.000 K | 375.000 K | 497.000 K | 340.000 K | 323.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -21.000 K | -9.000 K | -6.000 K | -22.000 K | 0.000 | -95.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 21.000 K | 9.000 K | 6.000 K | 22.000 K | 0.000 | 95.000 K | |
| Cash Change | -9.548 M | 39.975 M | -13.684 M | -5.961 M | 33.788 M | -17.780 M | 33.773 M |